Get 20M+ Full-Text Papers For Less Than $1.50/day. Subscribe now for You or Your Team.

Learn More →

Cetuximab is an active treatment of metastatic and chemorefractory thymoma

Cetuximab is an active treatment of metastatic and chemorefractory thymoma http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Frontiers in Bioscience Unpaywall

Cetuximab is an active treatment of metastatic and chemorefractory thymoma

Frontiers in BioscienceJan 1, 2007

Cetuximab is an active treatment of metastatic and chemorefractory thymoma

Frontiers in BioscienceJan 1, 2007

Loading next page...
 
/lp/unpaywall/cetuximab-is-an-active-treatment-of-metastatic-and-chemorefractory-5yb089l804

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Unpaywall
ISSN
1093-4715
DOI
10.2741/2098
Publisher site
See Article on Publisher Site

Abstract

Journal

Frontiers in BioscienceUnpaywall

Published: Jan 1, 2007

There are no references for this article.